Mirum Pharmaceuticals Inc (MIRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 233,245 | 302,843 | 286,326 | 303,059 | 297,228 |
| Marketable Securities | 45,126 | N/A | N/A | 2,971 | 32,726 |
| Receivables | 60,430 | 54,999 | 67,968 | 47,834 | 35,326 |
| Inventories | 20,438 | 21,606 | 22,312 | 22,250 | 8,509 |
| TOTAL | $367,829 | $389,465 | $387,541 | $388,579 | $383,518 |
| Non-Current Assets | |||||
| PPE Net | 1,101 | 501 | 706 | 787 | 866 |
| Investments And Advances | 17,075 | 0 | 0 | 0 | 0 |
| Intangibles | 261,768 | 257,443 | 252,925 | 258,338 | 56,437 |
| Other Non-Current Assets | 12,981 | 4,553 | 5,449 | 2,938 | 2,767 |
| TOTAL | $292,925 | $262,497 | $259,080 | $262,063 | $60,070 |
| Total Assets | $660,754 | $651,962 | $646,621 | $650,642 | $443,588 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,842 | 15,983 | 7,416 | 7,369 | 14,446 |
| Accrued Expenses | 101,394 | 89,568 | 78,544 | 66,213 | 42,693 |
| TOTAL | $112,308 | $105,909 | $87,064 | $74,664 | $58,203 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 319,458 | 311,450 | 310,887 | 306,897 | 306,775 |
| TOTAL | $319,458 | $311,450 | $310,887 | $306,897 | $306,775 |
| Total Liabilities | $431,766 | $417,359 | $397,951 | $381,561 | $364,978 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 47,707 | 47,133 | 47,003 | 46,614 | 38,298 |
| Common Shares | 5 | 5 | 5 | 5 | 4 |
| Retained earnings | -606,156 | -581,518 | -556,239 | -520,580 | -496,992 |
| Other shareholders' equity | -477 | -13 | 1,644 | -1,458 | 76 |
| TOTAL | $228,988 | $234,603 | $248,670 | $269,081 | $78,610 |
| Total Liabilities And Equity | $660,754 | $651,962 | $646,621 | $650,642 | $443,588 |